We are focused on the Drug Discovery, Development of, Bioprocesses and Global Marketing of Biosimilars. Our primary focus is to develop innovative and effective Biopharmaceuticals in diabetology, oncology, cardiology, virology. Biosimilars such as Recombinant Human Growth Hormone, Recombinant Human Insulin, Human Insulin analog LISPRO, Human Insulin analog Glargine, Human Insulin analog Aspart, Human G-CSF, Human GM-CSF, Rec. Erythropoeitein and Rec. Rituximab. These products are in various stages of development and regulatory clearances.

To explore the scientific creativity of a scientist, a conducive environment is a primary requisite. Biogenomics has developed a state-of-art research facility equipped with the latest tools of research in modern biotechnology which enables facilities such as Contract Research as well as Contract Manufacturing.